We report a case of long-standing SLE which presented with symptomatic muscle vasculitis on a background of photosensitivity, arthralgia and myalgia. The diagnosis was complicated by cardiomyopathy, nephrotic syndrome and diabetes. We highlight the benefits of aggressive treatment in severe disease and the importance of recognising and treating comorbidity especially in relation to atherosclerosis.
Lim KL , Addul-Wahahb R , Lowe J , Powell RJ . Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters . Ann Rheum Dis1994; 543; 178-182
3.
Tan EM , Cohen AS , Fries JF et al. The 1982 revised critieria for the classification of systemic lupus erythematosus . Arthritis Rheum1982; 25: 1271-1277 .
4.
Ward M . Premature cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus . Arthritis Rheum1999; 42: 338-346 .
5.
Borba E , Bonfa E . Dyslipoproteinaemias in systemic lupus erythematosus: influence of disease, activity and anticardinolipin antibodies . Lupus1997; 6: 533-539 .
6.
Leong K , Koh E , Feng P , Boey M . Lipid profiles in patients with systemic lupus erythematosus . J Rheumatol1994; 21: 1264-1267 .
7.
Lahita R , Rivkin E , Cavanagh I , Romano P.Low levels of total cholesterol, high-density lipoprotein and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus . Arthritis Rheum1993; 36: 1566-1574 .
8.
Harats D , George J , Levy Y et al. Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus . QJM1999; 92: 57-59 .
9.
Merrill J , Rivkin E , Shen C , Lahita R . Selection of a gene for apolipoprotein A1 using autoantibodies from a patient with systemic lupus erythematosus . Arthritis Rheum1995; 38: 1655-1659 .
10.
George J , Harats D , Gilburd B et al. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis . Lupus1999; 8: 220-226 .
11.
Hodis H , Quismorio F , Wickham E , Blankenhorn D . The lipid, lipoprotein and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosusJ Rheumatol1993; 20: 661-665 .
12.
Rahman P , Gladman D , Urowitz M et al. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs . J Rheumatol1999; 26: 325-330 .
13.
Wallace D , Linker M , Metzer A , Stecher V . The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolaemia and cytokines in SLE . Lupus1993; 2(Suppl 1): S13-S51 .
14.
Naarendorp M , Kerr L , Khan A , Ornstein M . Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 casesJ Rheumatol1999; 26: 2257-2260 .
